Participate in Research

REUNION Study for Moms Experiencing Postpartum Depression
Protocol: STUDY00008365
Full Title
A Multicenter, Randomized, Double-Blind, Parallel-Group Dose-Controlled Study Evaluating the Safety and Efficacy of RE104 for Injection in the Treatment of Patients with Postpartum Depression (PPD)
Description
The University at Buffalo (UB) Department of Psychiatry is looking for moms experiencing symptoms of postpartum depression (PPD) for a new clinical trial. The goal of this study is to see if a new study drug (RE104) can help to treat symptoms of PPD.

After attending a screening visit, eligible participants will complete a Dosing Session and will be randomly assigned (which happens by chance, like flipping a coin) to receive either a low dose (1.5mg) or a high dose (30mg) of the study drug. The visit will last for 8 hours after receiving the study drug or until the effects have worn off. This Dosing Session will take place in a comfortable room where participants can sit, lay down, listen to music, and relax. There will then be 7 follow-up sessions (4 in person and 3 via telephone) to help the study team learn about the effects of the study drug on treating PPD symptoms.

Participants can earn up to $852 for completing all study parts.
Compensation: Yes
?
Compensation may include cash, checks, gift cards, debit cards, or incentives like gift baskets, technology items, or merchandise.
Eligibility
-Moms aged 18 to 45 years old
-Have had a baby sometime in the last 12 months
-Experiencing signs of depression
-Have a caretaker who can look after your baby during the Dosing Session and for 24 hours after dosing
Age Group: Adults
Principal Investigator: BETH SMITH
ClinicalTrials.gov: Open Study
Contact(s)
NANCY DESU
ndesu@buffalo.edu
+1 716-898-3434
Christopher Suchan
cssuchan@buffalo.edu
+1 716-898-4038

Want to Learn More?

Let us know how the study team can reach you. If you do not hear back within 2 business days, then reach out to the study team directly at the contact information above and someone will assist you.

Your information will be shared only with the research study team and administrative staff for recruitment and will remain confidential. Your information will be stored until study recruitment is closed. Should you no longer want this information to be provided in the aforementioned ways, please contact the study team directly.

Study teams can login to review submissions